Search Results - Schmied, Bastian J.

  • Showing 1 - 10 results of 10
Refine Results
  1. 1
    The novel deubiquitinase inhibitor b-AP15 induces direct and NK cell-mediated antitumor effects in human mantle cell lymphoma

    The novel deubiquitinase inhibitor b-AP15 induces direct and NK cell-mediated antitumor effects in human mantle cell lymphoma by Kropp, Korbinian N., Maurer, Stefanie, Rothfelder, Kathrin, Schmied, Bastian J., Clar, Kim L., Schmidt, Moritz, Strunz, Benedikt, Kopp, Hans-Georg, Steinle, Alexander, Grünebach, Frank, Rittig, Susanne M., Salih, Helmut R., Dörfel, Daniela

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Receptor Activator of NF-κB (RANK) Confers Resistance to Chemotherapy in AML and Associates with Dismal Disease Course

    Receptor Activator of NF-κB (RANK) Confers Resistance to Chemotherapy in AML and Associates with Dismal Disease Course by Clar, Kim, Weber, Lisa, Schmied, Bastian, Heitmann, Jonas, Marconato, Maddalena, Tandler, Claudia, Schneider, Pascal, Salih, Helmut

    Published in Cancers
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    An Fc-Optimized CD133 Antibody for Induction of NK Cell Reactivity against B Cell Acute Lymphoblastic Leukemia

    An Fc-Optimized CD133 Antibody for Induction of NK Cell Reactivity against B Cell Acute Lymphoblastic Leukemia by Riegg, Fabian, Lutz, Martina S, Schmied, Bastian J, Heitmann, Jonas S, Queudeville, Manon, Lang, Peter, Jung, Gundram, Salih, Helmut R, Märklin, Melanie

    Published in Cancers
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    An Fc-Optimized CD133 Antibody for Induction of Natural Killer Cell Reactivity against Colorectal Cancer

    An Fc-Optimized CD133 Antibody for Induction of Natural Killer Cell Reactivity against Colorectal Cancer by Schmied, Bastian J, Riegg, Fabian, Zekri, Latifa, Grosse-Hovest, Ludger, Bühring, Hans-Jörg, Jung, Gundram, Salih, Helmut R

    Published in Cancers
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Induction of NK Cell Reactivity against B-Cell Acute Lymphoblastic Leukemia by an Fc-Optimized FLT3 Antibody

    Induction of NK Cell Reactivity against B-Cell Acute Lymphoblastic Leukemia by an Fc-Optimized FLT3 Antibody by Schmied, Bastian J, Lutz, Martina S, Riegg, Fabian, Zekri, Latifa, Heitmann, Jonas S, Bühring, Hans-Jörg, Jung, Gundram, Salih, Helmut R

    Published in Cancers
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    Prognostic relevance of HER2/neu in acute lymphoblastic leukemia and induction of NK cell reactivity against primary ALL blasts by trastuzumab

    Prognostic relevance of HER2/neu in acute lymphoblastic leukemia and induction of NK cell reactivity against primary ALL blasts by trastuzumab by Haen, Sebastian P, Schmiedel, Benjamin J, Rothfelder, Kathrin, Schmied, Bastian J, Dang, Truong-Minh, Mirza, Nora, Möhle, Robert, Kanz, Lothar, Vogel, Wichard, Salih, Helmut R

    Published in Oncotarget
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    Immunocytokines with Target Cell-Restricted IL-15 Activity for Induction of NK Cell Reactivity Against Acute Myeloid Leukemia (AML)

    Immunocytokines with Target Cell-Restricted IL-15 Activity for Induction of NK Cell Reactivity Against Acute Myeloid Leukemia (AML) by Schmied, Bastian J., Zekri, Latifa, Pflügler, Martin, Märklin, Melanie, Kanz, Lothar, Jung, Gundram, Salih, Helmut R.

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Abstract 2860: A CD135 immunocytokine with target cell-restricted IL-15 activity for treatment of AML

    Abstract 2860: A CD135 immunocytokine with target cell-restricted IL-15 activity for treatment of AML by Lutz, Martina S., Schmied, Bastian J., Riegg, Fabian, Zekri, Latifa, Heitmann, Jonas S., Maerklin, Melanie, Pfluegler, Martin, Jung, Gundram, Salih, Helmut R.

    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    Abstract 3957: Receptor Activator of NF-κB (RANK) confers resistance to chemotherapy in AML and associates with dismal disease course

    Abstract 3957: Receptor Activator of NF-κB (RANK) confers resistance to chemotherapy in AML and associates with dismal disease course by Clar, Kim L., Weber, Lisa M., Schmied, Bastian J., Heitmann, Jonas S., Marconato, Maddalena, Tandler, Claudia, Schneider, Pascal, Salih, Helmut R.

    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    Observational cohort study of rilpivirine (RPV) utilization in Europe

    Observational cohort study of rilpivirine (RPV) utilization in Europe by Cozzi-Lepri, Alessandro, Peters, Lars, Pelchen-Matthews, Annegret, Neesgaard, Bastian, De Wit, Stephane, Johansen, Isik Somuncu, Edwards, Simon, Stephan, Christoph, Adamis, Georgios, Staub, Therese, Zagalo, Alexandra, Domingo, Pere, Elbirt, Daniel, Kusejko, Katharina, Brännström, Johanna, Paduta, Dzmitry, Trofimova, Tatyana, Szlavik, Janos, Zilmer, Kai, Losso, Marcello, Van Eygen, Veerle, Pai, Helen, Lundgren, Jens, Mocroft, Amanda

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: